Aro Biotherapeutics Appoints Glenn Crater, MD, as Chief Medical Officer [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Crater, MD, as chief medical officer (CMO). Dr. Crater will lead the development of Aro's pipeline of Centyrin-based, tissue-targeted medications, including the company's lead product candidate ABX1100, a novel potential treatment for Pompe disease. "Dr. Crater joins our team at an opportune time, with our lead product, ABX1100, in early-stage development for patients with late-onset Pompe disease," said Susan Dillon, PhD, co-founder, president and chief executive officer of Aro. "Glenn is a proven leader in our industry, with deep and broad experience in clinical development. We are thrilled to have him on board to help us advance ABX1100 and guide our other development programs." "Aro Biotherapeutics has demonstrated a mastery of cutting-edge technology in their ability to deliver tissue-targeted siRNA therapies. I am excited to join the company just as ABX1100 enters the clinic in Pompe disease, a debilitating and deadly disease for which there are limited treatment options," c
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Yahoo Finance [Yahoo! Finance]Yahoo! Finance
- 3 trial readouts that could shake up the obesity market this year [Yahoo! Finance]Yahoo! Finance
- How Trump’s Greenland Plan Could Hit Ozempic, Legos and Hearing Aids [The New York Times]The New York Times
- Trump meets with Walmart CEO: How ready is retailer for tariffs? [Yahoo! Finance]Yahoo! Finance
- Trump meets with Walmart CEO: How ready is retailer for tariffs? [Yahoo! Finance Canada]Yahoo! Finance Canada
NVO
Earnings
- 11/7/24 - Beat
NVO
Sec Filings
- 12/20/24 - Form 6-K
- 12/20/24 - Form 6-K
- 12/18/24 - Form 6-K
- NVO's page on the SEC website